Overview

Abiraterone acetate is a restricted-distribution anti-cancer medicine, so for B2B buyers the deciding factors are supply continuity, registration status, and documentation integrity rather than molecule novelty. ABIRAPRO delivers abiraterone 250 mg film-coated tablets in 120-tablet boxes, sized for a full month of the labelled once-daily regimen when combined with prednisone. This guide covers the procurement, storage, and paperwork checklist that purchasing teams need before committing to a supplier. Confirming the manufacturer's licence and batch release evidence up front prevents costly customs holds and therapy interruptions.

How It Works

Abiraterone acetate inhibits CYP17A1, the enzyme responsible for androgen biosynthesis in the adrenal glands and tumour tissue, thereby lowering extragonadal androgen production that fuels prostate cancer even after castration. When paired with a corticosteroid such as prednisone, it suppresses the upstream drive of the androgen axis. For procurement, the practical implication is that the product ships as a finished tablet requiring no reconstitution, which simplifies logistics compared with injectable hormone therapies. Buyers should match the 250 mg strength to the prescribed daily loading and the co-prescribed steroid.

Indications

Abiraterone is used with prednisone for metastatic castration-resistant prostate cancer and for newly diagnosed high-risk metastatic hormone-sensitive disease. The 120-tablet pack supports the standard monthly course. Sourcing teams should align order volumes with confirmed prescriptions, since the medicine is prescription-only and subject to controlled import in many markets. Verification of the intended indication helps right-size inventory and avoids overstock of a product with a defined clinical pathway.

Dosage & Administration

One 250 mg tablet is taken orally once daily on an empty stomach, at least two hours after and one hour before food, together with prednisone 5 mg twice daily or 10 mg once daily. A 120-tablet box provides one month of therapy. Therapy is continuous alongside androgen deprivation. Tablets are swallowed whole; no splitting or crushing is recommended. Dose holds for toxicity follow the prescribing information and local guidance.

Storage & Sourcing

Store below 30°C in the original container, protected from humidity. Because abiraterone is a prescription oncology product, B2B orders require supplier licensing, a valid import permit, and a certificate of analysis per batch. Compare the manufacturer's GMP certificate, shelf life remaining on dispatch, and lead time before signing. Cold-chain is not mandatory for the tablets, but temperature-controlled transit is advised in hot climates to protect blister integrity. Stage inventory against patient cohorts to keep continuous therapy uninterrupted.

FAQ

Q: What documents should a B2B buyer request before ordering abiraterone? A: Request the supplier's wholesale licence, the product registration or import permit for your market, and a batch-specific certificate of analysis plus GMP evidence.

Q: Does ABIRAPRO require refrigerated shipping? A: No. The tablets are stored below 30°C, but temperature-protected transport is recommended in hot regions to preserve packaging and potency.

Q: Why is prednisone part of every abiraterone order? A: Abiraterone depletes cortisol via CYP17 blockade, so co-prescribed steroids prevent mineralocorticoid excess; orders should plan both items together.